You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

Details for Patent: 8,071,644


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,071,644 protect, and when does it expire?

Patent 8,071,644 protects EPIDUO and is included in one NDA.

This patent has thirty-five patent family members in twenty-two countries.

Summary for Patent: 8,071,644
Title:Combinations of adapalene and benzoyl peroxide for treating acne lesions
Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
Inventor(s): Abou-Chacra Vernet; Marie-line (Nice, FR), Gross; Denis (Callian, FR), Loesche; Christian (Valbonne, FR), Poncet; Michel (Mougins, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:12/318,937
Patent Claim Types:
see list of patent claims
Use; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,071,644

Introduction

The United States Patent 8,071,644, hereafter referred to as the '644 Patent, is a significant intellectual property asset that has been the subject of various legal and commercial interests. This article delves into the details of the patent's scope, claims, and the broader patent landscape in which it operates.

Overview of the Patent

The '644 Patent is associated with a specific pharmaceutical product, as evident from legal documents involving infringement disputes. This patent, along with others such as the '537, '362, '543, and '305 Patents, is crucial in the context of pharmaceutical intellectual property[1].

Patent Claims

Patent claims are the heart of any patent, defining the scope of protection granted to the patent holder. For the '644 Patent, the claims are specific to the composition, method of use, and indications of the pharmaceutical product.

  • Composition Claims: These claims define the specific formulation of the drug, including the active ingredients, their proportions, and any other components.
  • Method of Use Claims: These claims outline the approved uses of the drug, including the medical conditions it is intended to treat and the dosage instructions.
  • Indication Claims: These specify the particular medical conditions or diseases for which the drug is approved[1].

Infringement and Inducement

The '644 Patent has been involved in infringement disputes, particularly with generic drug manufacturers seeking to enter the market. The legal framework under 35 U.S.C. § 271(e)(2)(A) is critical here, as it addresses the submission of Abbreviated New Drug Applications (ANDAs) that could potentially infringe on existing patents. If a generic manufacturer submits an ANDA for a product that would infringe on the claims of the '644 Patent upon FDA approval, it could be held liable for infringement[1].

Patent Landscape

The patent landscape surrounding the '644 Patent includes several other related patents, such as the '537, '362, '543, and '305 Patents. These patents collectively protect various aspects of the pharmaceutical product, including its composition, method of manufacture, and use.

  • Related Patents: The '537, '362, '543, and '305 Patents cover different but complementary aspects of the product. For instance, the '362 Patent might cover a specific method of manufacturing, while the '543 Patent could cover additional indications or formulations[1].
  • Patent Extensions and Exclusivity: These patents may also have extensions or additional periods of exclusivity, which can further complicate the landscape and extend the period during which generic competition is barred[1].

Legal and Regulatory Framework

The U.S. Patent and Trademark Office (USPTO) plays a central role in the granting and enforcement of patents. Here are some key aspects of the legal and regulatory framework relevant to the '644 Patent:

  • USPTO Resources: The USPTO provides various tools and resources for patent searching, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources are essential for understanding the prior art and the scope of existing patents[4].
  • Infringement Litigation: The '644 Patent has been involved in litigation, with the patent holders seeking to enforce their rights against alleged infringers. This includes seeking permanent injunctive relief to prevent the manufacture, sale, or importation of infringing products[1].

Economic and Commercial Impact

The '644 Patent has significant economic and commercial implications. Here are a few key points:

  • Revenue Protection: By enforcing the '644 Patent, the patent holders aim to protect their revenue streams from generic competition. This is particularly important in the pharmaceutical industry, where patent protection can be a major factor in a drug's profitability[1].
  • Market Exclusivity: The patent and any associated exclusivity periods ensure that the patent holder maintains market exclusivity for the protected product, which can be crucial for recouping research and development investments[1].

Expert Insights and Statistics

Industry experts and legal practitioners often weigh in on the complexities of patent litigation and the importance of robust patent protection.

"Patent protection is crucial for pharmaceutical companies to recoup their significant investments in research and development," said Andrei Iancu, former Undersecretary of Commerce for IP and Director of the USPTO[5].

Statistics from the USPTO also highlight the importance of patent claims and scope. For instance, the Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014, which can help in understanding the trends and complexities of patent scope[3].

Public Access and Search Tools

Public access to patent information is facilitated through various tools and resources provided by the USPTO:

  • Patent Public Search: This tool allows users to search for existing patents and published patent applications, providing enhanced access to prior art[4].
  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family for a specific application[4].

Future Developments and Small Claims Courts

There are ongoing discussions and studies about the feasibility of a small claims patent court, which could potentially simplify and reduce the costs associated with patent litigation.

"A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, particularly for smaller entities," noted a report by the Administrative Conference of the United States (ACUS)[5].

Key Takeaways

  • Patent Claims: The '644 Patent's claims are specific to the composition, method of use, and indications of the pharmaceutical product.
  • Infringement: The patent has been involved in infringement disputes, particularly with generic drug manufacturers.
  • Related Patents: The patent landscape includes other related patents that collectively protect various aspects of the product.
  • Legal Framework: The USPTO and relevant statutes play a crucial role in the granting and enforcement of patents.
  • Economic Impact: The patent has significant economic and commercial implications, including revenue protection and market exclusivity.

FAQs

Q: What is the '644 Patent related to? A: The '644 Patent is related to a specific pharmaceutical product, including its composition, method of use, and indications.

Q: Why is the '644 Patent important in the pharmaceutical industry? A: The '644 Patent is crucial for protecting the revenue streams and market exclusivity of the patent holder, allowing them to recoup investments in research and development.

Q: How can one search for patents related to the '644 Patent? A: One can use the USPTO's Patent Public Search tool, Global Dossier, and other resources provided by the USPTO to search for related patents.

Q: What are the implications of infringement on the '644 Patent? A: Infringement on the '644 Patent can result in legal action, including permanent injunctive relief and monetary damages.

Q: Are there any ongoing developments in patent litigation that could affect the '644 Patent? A: Yes, there are discussions about the establishment of a small claims patent court, which could simplify and reduce the costs associated with patent litigation.

Sources

  1. IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION - [PDF Document][1]
  2. U.S. Patent and Trademark Office (USPTO) | USAGov - [USAGov][2]
  3. Patent Claims Research Dataset - USPTO - [USPTO][3]
  4. Search for patents - USPTO - [USPTO][4]
  5. U.S. Patent Small Claims Court - [ACUS][5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,071,644

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF ACNE ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

Foreign Priority and PCT Information for Patent: 8,071,644

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France06 52968Jul 13, 2006

International Family Members for US Patent 8,071,644

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 061989 ⤷  Try for Free
Australia 2007274288 ⤷  Try for Free
Brazil PI0713182 ⤷  Try for Free
Canada 2656456 ⤷  Try for Free
China 101541320 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.